0001213900-21-029677.txt : 20210527 0001213900-21-029677.hdr.sgml : 20210527 20210527172937 ACCESSION NUMBER: 0001213900-21-029677 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210527 DATE AS OF CHANGE: 20210527 EFFECTIVENESS DATE: 20210527 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Advanced Bio Development, Inc. CENTRAL INDEX KEY: 0001696505 IRS NUMBER: 320257410 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-375082 FILM NUMBER: 21974396 BUSINESS ADDRESS: STREET 1: 270 SYLVAN AVENUE STREET 2: SUITE 2230 CITY: ENGLEWOOD CLIFFS STATE: NJ ZIP: 07632 BUSINESS PHONE: 845.365.3838 MAIL ADDRESS: STREET 1: 270 SYLVAN AVENUE STREET 2: SUITE 2230 CITY: ENGLEWOOD CLIFFS STATE: NJ ZIP: 07632 D/A 1 primary_doc.xml X0708 D/A LIVE 0001696505 Advanced Bio Development, Inc. 270 SYLVAN AVENUE SUITE 2230 ENGLEWOOD CLIFFS NJ NEW JERSEY 07632 (845) 365-3838 DELAWARE None None Corporation true Mark French 270 Sylvan Avenue Suite 2230 Englewood Cliffs NJ NEW JERSEY 07632 Executive Officer Director M. Todd Bartee 599 West Putnam Avenue Greenwich CT CONNECTICUT 06830 Director Michael Farello 599 West Putnam Avenue Greenwich CT CONNECTICUT 06830 Director Michael Tannenbaum 270 Sylvan Avenue Englewood Cliffs NJ NEW JERSEY 07632 Director Scott Greene 270 Sylvan Avenue Suite 2230 Englewood Cliffs NJ NEW JERSEY 07632 Executive Officer Dennis Robertson 270 Sylvan Avenue Suite 2230 Englewood Cliffs NJ NEW JERSEY 07632 Director Kawhi Leonard 270 Sylvan Avenue Suite 2230 Englewood Cliffs NJ NEW JERSEY 07632 Director Ralph Ferrante 270 Sylvan Avenue Suite 2230 Englewood Cliffs NJ NEW JERSEY 07632 Director Other Decline to Disclose 06b true 0001213900-20-025762 2020-09-01 false true true false 0 16000000 14065879 1934121 The Company has increased the offering size to $16,000,000 of new investment. We are amending this amount to include all securities sold since September 1, 2020. true 0 23 0 0 0 true Proceeds may be used to pay overhead and other corporate expenses which could include salaries. false Advanced Bio Development, Inc. /s/ Mark French Mark French Chief Executive Officer 2021-05-27